Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 54%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is a global health services company that specializes in integrated health services such as medical, dental, behavioral health, pharmacy, vision, and supplemental benefits. The company has shown strong performance in its pharmacy benefits management and specialty pharmacy services, driven by key contracts and partnerships. Its strategic initiatives, such as the successful implementation of its rebate-free PBM model and the adoption of its Evernorth platform, have also contributed to its solid financials. The company's diversified revenue mix and focus on sustainable development also make it an attractive investment prospect.

Bears say

Cigna Group is facing several risks, including potential difficulties with accurately pricing and managing healthcare costs, margin erosion in its PBM business as it transitions to a rebate-free model, and potential client losses for its PBM segment. While the company's price-to-earnings ratio is currently at the lower end of its historical range, we believe it is justified given its efforts to address these risks and the company's commitment to diversity and gender parity. Additionally, its use of AI technology to predict and manage healthcare costs may provide cost savings for its customers in the long run.

Cigna (CI) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 54% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 13 analysts, Cigna (CI) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $343.69, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $343.69, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.